Vertex Pharmaceuticals Incorporated EPS (Earnings per Share) 2008–2025
Vertex Pharmaceuticals Incorporated reported $15.32 of earnings per share for fiscal 2025. That was 836.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +48.9%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $15.32 | +836.5% |
| FY 2024 | $-2.08 | -115.0% |
| FY 2023 | $13.89 | +8.3% |
| FY 2022 | $12.82 | +42.3% |
| FY 2021 | $9.01 | -12.4% |
| FY 2020 | $10.29 | +128.2% |
| FY 2019 | $4.51 | -44.3% |
| FY 2018 | $8.09 | +677.9% |
| FY 2017 | $1.04 | +326.1% |
| FY 2016 | $-0.46 | +80.1% |
| FY 2015 | $-2.31 | +26.4% |
| FY 2014 | $-3.14 | -58.6% |
| FY 2013 | $-1.98 | -296.0% |
| FY 2012 | $-0.50 | -457.1% |
| FY 2011 | $0.14 | +103.7% |
| FY 2010 | $-3.77 | -1.6% |
| FY 2009 | $-3.71 | -13.5% |
| FY 2008 | $-3.27 | — |
Source: Vertex Pharmaceuticals Incorporated SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open VRTX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Vertex Pharmaceuticals Incorporated reported $15.32 of earnings per share for fiscal 2025. That was 836.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +48.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Vertex Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVertex Pharmaceuticals Incorporated — frequently asked questions
What is Vertex Pharmaceuticals Incorporated's earnings per share?
Vertex Pharmaceuticals Incorporated (VRTX) reported earnings per share of $15.32 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Vertex Pharmaceuticals Incorporated's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.